Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Retina Pathology”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01051700
What this trial is testing

A Safety Study in Healthy Volunteers to Evaluate Safety, How Fast the Drug is Absorbed, and the Side Effects of the Drug in Humans

Who this might be right for
Macular Degeneration
GlaxoSmithKline 72
Testing effectiveness (Phase 2)Study completedNCT00467935
What this trial is testing

Scotoma Reduction in AMD Patients Treated With Ranibizumab

Who this might be right for
Macular Degeneration
Retina Research Foundation 20
Not applicableLooking for participantsNCT07228091
What this trial is testing

Surgical Procedure Efficiency Evaluation stuDy

Who this might be right for
CataractVitreous HemorrhageRetinal Detachment+2 more
Alcon Research 180
Post-approval studies (Phase 4)Study completedNCT02689518
What this trial is testing

EAGLE: Evaluating Genotypes Using Intravitreal Aflibercept Injection

Who this might be right for
Macular DegenerationWet Macular Degeneration
University of California, San Diego 50
Not applicableStudy completedNCT03728660
What this trial is testing

Design and Clinical Evaluation of a Smartphone-based Low Vision Enhancement System

Who this might be right for
Low Vision
Johns Hopkins University 88
Testing effectiveness (Phase 2)Study completedNCT03038880
What this trial is testing

Study to Evaluate Faricimab (RO6867461; RG7716) for Extended Durability in the Treatment of Neovascular Age Related Macular Degeneration

Who this might be right for
Neovascularization, ChoroidalMacular Degeneration, Age-Related
Hoffmann-La Roche 76
Testing effectiveness (Phase 2)Study completedNCT03953079
What this trial is testing

A Depot Formulation of Sunitinib Malate (GB-102) Compared to Aflibercept in Subjects With Wet AMD

Who this might be right for
Neovascular Age-Related Macular Degeneration
Graybug Vision 56
Large-scale testing (Phase 3)Study completedNCT00198510
What this trial is testing

Safety and Efficacy Study of Vitrase for Clearance of Severe Vitreous Hemorrhage

Who this might be right for
Vitreous HemorrhageDiabetic Retinopathy
Bausch & Lomb Incorporated 750
Large-scale testing (Phase 3)Study completedNCT00429962
What this trial is testing

Study Comparing Ranibizumab Monotherapy With Combined Verteporfin Therapy in Subfoveal CNV

Who this might be right for
Choroidal NeovascularizationAge-Related Macular Degeneration
University Hospital, Basel, Switzerland 40
Not applicableStudy completedNCT01880788
What this trial is testing

Genetic Analysis of Chronic Central Serous Chorioretinopathy Masquerading as Neovascular AMD

Who this might be right for
Age Related Macular DegenerationChoroidal NeovascularizationCentral Serous Chorioretinopathy
Sequenom, Inc. 152
Not applicableActive Not RecruitingNCT06965660
What this trial is testing

Population Cohort Set-up for the Epidemiological Assessment of Balance Disorders in Elderly People

Who this might be right for
Balance DisordersAccidental FallsFrailty+1 more
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina 1,300
Not applicableStudy completedNCT00656903
What this trial is testing

High Speed Indocyanine Green Angiography Findings in Ranibizumab Treatment for Wet Age-related Macular Degeneration

Who this might be right for
Macular Degeneration
National Eye Institute (NEI) 75
Not applicableStudy completedNCT00231010
What this trial is testing

Molecular Genetics of Retinal Degenerations

Who this might be right for
Retinal DegenerationRetinitis Pigmentosa
National Eye Institute (NEI) 3,549
Post-approval studies (Phase 4)UnknownNCT05802108
What this trial is testing

Effect of PCSK9 Inhibitor on Retinal Microvessels in Patients With Coronary Heart Disease After Intensive Lipid-lowering Therapy

Who this might be right for
Adverse Effect of Cardiovascular Medications (Diagnosis)
Zibo Central Hospital 60
Testing effectiveness (Phase 2)Study completedNCT00363714
What this trial is testing

A Dose Escalation Trial of an Intravitreal Injection of Sirna-027 in Patients With Subfoveal Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD)

Who this might be right for
Age-Related Macular DegenerationChoroidal Neovascularization
Allergan 26
Testing effectiveness (Phase 2)Ended earlyNCT00509548
What this trial is testing

Open-Label, Pilot Study of TG100801 in Patients With Choroidal Neovascularization Due to AMD

Who this might be right for
Macular DegenerationChoroidal Neovascularization
TargeGen 7
Not applicableStudy completedNCT01698749
What this trial is testing

Effect of Intravitreal Long Acting Dexamethasone Implant, Ozurdex in Patients With Diabetic Macular Edema

Who this might be right for
Diabetic Macular EdemaMacular Edema, CystoidVision Disorders+1 more
Post Graduate Institute of Medical Education and Research, Chandigarh 61
Not applicableStudy completedNCT05012358
What this trial is testing

Genomic Profiling of Mitochondrial Disease - Imaging Analysis for Precise Mitochondrial Medicine

Who this might be right for
Mitochondrial MyopathiesMitochondrial DNA MutationMitochondrial Diseases+2 more
Mayo Clinic 9
Not applicableStudy completedNCT03451578
What this trial is testing

Alpha MSH in Ocular Disease

Who this might be right for
Advanced Dry Macular Degeneration
Duke University 54
Testing effectiveness (Phase 2)Study completedNCT00564148
What this trial is testing

Intravitreal Avastin in Proliferative Retinopathies

Who this might be right for
Retinal Neovascularization
Ophthalmological Association Edelweiss 100
Next Page